TAP, Abbott, Takeda reach $1.86 million settlement with Illinois AG
Pharma Compliance Alert, September 6, 2006
TAP, Abbott, and Takeda have reached a $1.86 million deal with Illinois Attorney General Lisa Madigan to settle allegations that the companies published inflated prices for their prostate cancer medication Lupron.
Madigan filed a lawsuit in 2005 against the companies for violations related to the average wholesale price reporting, according to her office. The suit alleged that the drug makers fraudulently published inflated prices, forcing government programs and Illinois Medicare consumers to overpay hundreds of millions of dollars in drug costs.
The settlement money will be distributed in the form of grants to 19 clinics throughout Illinois to provide cancer-related services to low-income patients.
Read more about the settlement on the Illinois AG's Web site.
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Big Pharma Performance Before, During and Beyond the Global Recession
This report assesses the performance of the leading 15 pharmaceutical companies up to, during and beyond the recent global...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- Capturing all necessary codes for IUD insertion and removal can be challenging
- QA:Coding multiple initial infusions
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Q&A tackles coding questions about injections and infusions
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- Case Management Monthly, June 2012
- Searched